Abstract
Pirnay JP, Blasdel BG, Bretaudeau L, Buckling A, Chanishvili N, Clark JR, Corte-Real S, Debarbieux L, Dublanchet A, De Vos D, Gabard J, Garcia M, Goderdzishvili M, Górski A, Hardcastle J, Huys I, Kutter E, Lavigne R, Merabishvili M, Olchawa E, Parikka KJ, Patey O, Pouilot F, Resch G, Rohde C, Scheres J, Skurnik M, Vaneechoutte M, Van Parys L, Verbeken G, Zizi M, Van den Eede G.
Quality and safety requirements for sustainable phage therapy products.
Pharm Res. 2015 Jul;32(7):2173-9. doi: 10.1007/s11095-014-1617-7. Epub 2015 Jan 14.
Quality and safety requirements for sustainable phage therapy products.
Pharm Res. 2015 Jul;32(7):2173-9. doi: 10.1007/s11095-014-1617-7. Epub 2015 Jan 14.
| Original language | English |
|---|---|
| Pages (from-to) | 2173-2179 |
| Number of pages | 7 |
| Journal | Pharmaceutical Research |
| Volume | 32 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 1 Jan 2015 |
Fingerprint
Dive into the research topics of 'Quality and Safety Requirements for Sustainable Phage Therapy Products'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver